Articles by Camille Mojica Rey

  1. Connecting Women Who Are Boardroom Ready
    4/1/2019

    The inside scoop on a program designed for women seeking board positions at biopharma companies. It’s more than just training; it’s networking assistance that is the real value.

  2. Doug Given: From Pharma To Redefining Healthcare
    3/1/2019

    A retired pharma executive decides to tackle the daunting task of revamping the U.S. healthcare system.

  3. Big Pharma’s Unique Approaches To Leadership Development
    1/2/2019

    To ensure that future leaders will be up to the challenges they will face, pharma companies are pursuing unique programs focused on problem-solving — sometimes sending employees to developing countries where they must tackle real-world problems.

  4. The Unique Challenges Facing Cannabis-based Pharma
    1/2/2019

    Now that the FDA has finally approved the first-ever pharmaceutical derived from the cannabis plant, will drug development — and success — in this niche finally take off?

  5. MD’s I270 Biotech Corridor: A Hub Within A Hub
    11/7/2018

    The larger BioHealth Capital Region, of which the I-270 biotech corridor is a part, currently ranks as the fifth largest biotech hub in the U.S. with 39,000 people employed by the industry.

  6. Biopharma Pioneer Returns To Small Company Roots
    10/4/2018

    When Celgene began pursuing an aggressive acquisition strategy, David Stirling, Ph.D., a cofounder, decided to leave and eventually start his own company, BioTheryX.

  7. From Big Pharma To Small Company Founder
    9/3/2018

    Don DeGolyer talks about the process he took to go from working at a Big Pharma like Sandoz to founding and running his own small specialty pharma company.

  8. Why And How To Close The Gender Gap In The Life Sciences
    9/3/2018

    Women in leadership roles in the biopharma industry say it is imperative that the industry’s gender gap problem be addressed — by both men and women. Because, if the current trend of women leaving the industry continues, this problem will become a worker-shortage problem and reduce innovation that is vital for industry growth.

  9. Biopharma Startups Seek Big Pharma Expertise
    8/2/2018

    Former Big Pharma employees are helping startups go further in the drug development process, and in return, small companies are offering those with Big Pharma experience a chance to see what it’s like to have a large impact on the trajectory of a small company.

  10. Biopharma Startups Take Advantage Of Open IPO Window
    6/1/2018

    Biopharma startups are enjoying a window of opportunity for successful IPOs that opened in mid-2017. CEOs share their experiences of going public, what is fueling IPOs, and tips for others thinking about making this important next step.